LXRX vs NFLX · rev $21.8M vs P/E 25, rev $12.56B
Lexicon Pharmaceuticals Inc (LXRX) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
LXRX currently screens at market cap $327.2M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the LXRX and NFLX stock pages for the full models.
Not investment advice.